M&A Deal Summary |
|
|---|---|
| Date | 2016-08-24 |
| Target | Telesta Therapeutics |
| Sector | Life Science |
| Buyer(s) | Liminal BioSciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 251 |
| Revenue | 1M CAD (2021) |
Liminal BioSciences is a biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics, and small-molecule drug development. The Company offers its state-of-the-art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics. Liminal BioSciences was founded in 1994 and is based in Laval, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (Quebec) | 1 of 1 |
| Country (Canada) | 2 of 2 |
| Year (2016) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-28 |
Emergent BioSolutions - Plasma Collection Facility
Winnipeg, Manitoba, Canada Emergent’s plasma collection center is an FDA and Health Canada licensed plasma collection facility. The plasma collection center is conveniently located in close proximity to the existing Emergent Winnipeg based cGMP manufacturing facility, which was recently announced as providing ProMetic with up to 250,000 liters of annual plasma processing capacity. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-15 |
Prometic Bioproduction
Laval, Quebec, Canada Prometic Bioproduction has developed the first-ever FDA-approved treatment for Congenital Plasminogen Deficiency. The new drug, called Ryplazim has been approved for the treatment of all the clinical manifestations of Plasminogen Deficiency, which can lead to blindness, respiratory failure, and other severe complications. |
Sell | - |
